| scholarly article | Q13442814 |
| P2093 | author name string | Yupo Ma | |
| Jianchang Yang | |||
| Li Chai | |||
| Daniel G Tenen | |||
| Jie He | |||
| Ailing Li | |||
| Chong Gao | |||
| Grace S Kao | |||
| Hiro Tatetu | |||
| Nikki R Kong | |||
| Shikiko Ueno | |||
| Youyang Yang | |||
| P2860 | cites work | Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages. | Q39937872 |
| Head and tail development of the Drosophila embryo involves spalt, a novel homeotic gene. | Q41090703 | ||
| CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons | Q41094042 | ||
| Dissecting the role of SALL4, a newly identified stem cell factor, in chronic myelogenous leukemia | Q42143823 | ||
| Loss of function of the homeobox gene Hoxa-9 perturbs early T-cell development and induces apoptosis in primitive thymocytes. | Q43419606 | ||
| PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention | Q59067116 | ||
| Biology of CD34+CD38- cells in lymphohematopoiesis | Q77737226 | ||
| Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1 | Q81119990 | ||
| Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family | Q24632196 | ||
| Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells | Q24669757 | ||
| Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells | Q24670084 | ||
| Novel mutations in the gene SALL4 provide further evidence for acro-renal-ocular and Okihiro syndromes being allelic entities, and extend the phenotypic spectrum | Q24675032 | ||
| Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy | Q24676719 | ||
| SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice | Q24685799 | ||
| spalt encodes an evolutionarily conserved zinc finger protein of novel structure which provides homeotic gene function in the head and tail region of the Drosophila embryo | Q26782010 | ||
| Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells | Q28137796 | ||
| Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells | Q28201183 | ||
| Okihiro syndrome is caused by SALL4 mutations | Q28209941 | ||
| Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex | Q28244856 | ||
| The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development | Q28247514 | ||
| Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells | Q28251945 | ||
| Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1 | Q28264106 | ||
| Murine inner cell mass-derived lineages depend on Sall4 function | Q28270152 | ||
| SALL4 is a key regulator of survival and apoptosis in human leukemic cells | Q28280516 | ||
| A Sall4 mutant mouse model useful for studying the role of Sall4 in early embryonic development and organogenesis | Q28282843 | ||
| IVIC syndrome is caused by a c.2607delA mutation in the SALL4 locus | Q28285272 | ||
| Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. | Q34418792 | ||
| SALL4 is a robust stimulator for the expansion of hematopoietic stem cells | Q35125909 | ||
| Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4 | Q35252403 | ||
| Antigen CD34+ marrow cells engraft lethally irradiated baboons | Q35587124 | ||
| Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells | Q37018962 | ||
| HOXA9 is required for survival in human MLL-rearranged acute leukemias | Q37129652 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hemopoiesis | Q919283 |
| P304 | page(s) | 1037-49 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Transfusion | Q15758500 |
| P1476 | title | SALL4 is a key transcription regulator in normal human hematopoiesis | |
| P478 | volume | 53 |
| Q38628583 | A New Indole Derivative Decreased SALL4 Gene Expression in Acute Promyelocytic Leukemia Cell Line (NB4) |
| Q28298834 | A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis |
| Q28597089 | Ex-vivo expansion of nonhuman primate CD34(+) cells by stem cell factor Sall4B |
| Q38805786 | Functional and clinical significance of SALL4 in breast cancer. |
| Q92645575 | High expression of SALL4 is associated with poor prognosis in squamous cell carcinoma of the uterine cervix |
| Q28300940 | Histone lysine-specific demethylase 1 (LSD1) protein is involved in Sal-like protein 4 (SALL4)-mediated transcriptional repression in hematopoietic stem cells |
| Q37024249 | Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma |
| Q37389409 | Leukemic survival factor SALL4 contributes to defective DNA damage repair |
| Q33618541 | Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis. |
| Q47747424 | SALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis |
| Q52597548 | SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts. |
| Q45903019 | SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway. |
| Q28273464 | SALL4, the missing link between stem cells, development and cancer |
| Q34718209 | Sall4 overexpression blocks murine hematopoiesis in a dose-dependent manner |
| Q28302909 | Stem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes |
| Q42122424 | Stem cell gene SALL4 in aggressive hepatocellular carcinoma: a cancer stem cell-specific target? |
| Q89767252 | Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4 |
| Q36998221 | The characteristic expression pattern of BMI-1 and SALL4 genes in placenta tissue and cord blood |
| Q40560744 | The next new target in leukemia: The embryonic stem cell gene SALL4. |
| Q42281102 | The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis |
| Q34655962 | Very small embryonic-like stem cells (VSELs) represent a real challenge in stem cell biology: recent pros and cons in the midst of a lively debate. |
Search more.